Clinical Trial Update: Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay [NA]

View source ↗

Summary

A completed clinical trial evaluating the clinical utility of a novel blood-based biomarker assay for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Qure Healthcare, LLC | Conditions: Alzheimer Disease (AD), Cognitive Decline | NA | Status: COMPLETED